Compare JAKK & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAKK | OSUR |
|---|---|---|
| Founded | 1995 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.0M | 247.6M |
| IPO Year | 1996 | 2000 |
| Metric | JAKK | OSUR |
|---|---|---|
| Price | $24.63 | $3.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $35.00 | $3.00 |
| AVG Volume (30 Days) | 103.6K | ★ 442.3K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.65% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $331,249,000.00 | $167,064,000.00 |
| Revenue This Year | $9.46 | $4.48 |
| Revenue Next Year | $4.36 | $7.76 |
| P/E Ratio | $188.69 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.87 | $2.08 |
| 52 Week High | $27.22 | $4.58 |
| Indicator | JAKK | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 38.41 |
| Support Level | $24.51 | $2.86 |
| Resistance Level | $26.35 | $3.93 |
| Average True Range (ATR) | 0.70 | 0.12 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 26.63 | 17.07 |
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells, and distributes toys and related kid-targeted consumer products, including kids' indoor and outdoor furniture, costumes, and various product lines in the sporting goods and home furnishings space. Its product offerings include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: Toys/Consumer Products and Costumes. It generates the majority of its revenue from the Toys/Consumer Products segment.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.